Delivery Order SPE2DB22D3401-SPE2DB25FT1YX

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.86, is a delivery order for 4,559,295,117 units of Ciprofloxacin HCL 250 MG Tablets. It is a firm-fixed price contract with a completion date of December 8, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This federal contract award, valued at $7,343.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin HCL 250 mg tablets in quantities of 100, with a completion date of September 26, 2022. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.93 firm fixed-price delivery order provides Ciprofloxacin HCL 250 mg tablets to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025 and is not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award is for the delivery of 4,557,636 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,429.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on June 24, 2022, with a completion date of June 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The delivery order is for $1,031.97 to supply 4,565,333 units of Ciprofloxacin HCL 250 mg tablets. This is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of 4,563,827,363 units of Ciprofloxacin HCL 250 MG tablets in 100-count bottles, with a potential value of $1,515.39 and a completion date of March 4, 2024. This delivery order is issued under a $999,999,999.00 indefinite delivery contract (IDC) that...
This federal contract award is valued at $2,949.01 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order. The contract is for the supply of 4,565,860,584 units of Ciprofloxacin HCL 250 MG tablets, a generic antibiotic medication. The contract has a firm fixed price and an ultimate completion date of September 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.48 firm fixed-price delivery order is for the supply of 4560629188 - Ciprofloxacin HCL 500 MG Tablets in 20s packaging. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,121.56 firm fixed-price delivery order is for the supply of Ciprofloxacin HCL 250 mg tablets. The contract has an ultimate completion date of February 9, 2022 and was awarded on February 8, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT1YX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,680.90, is for the delivery of Ciprofloxacin HCL 250 mg tablets in quantities of 100 per bottle. This is a firm fixed-price delivery order contract with a completion date of February 11, 2025. The contract has no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 10:42 AM